Influence of immunotherapy with interferon-α on regulatory T cells in renal cell carcinoma patients

Katsunori Tatsugami, Masatoshi Eto, Seiji Naito

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Interferon-α (IFN-α) has extremely broad effects on the immune system, and the influence of IFN-α on regulatory T (Treg) cells is not fully known. In this report, Treg cells were analyzed in patients with metastatic renal cell carcinoma (RCC) following IFN-α monotherapy or treatment with IFN-α and interleukin (IL)-2. CD4+ and FoxP3+ Treg cells were significantly decreased for 2 weeks after the initiation of IFN-α monotherapy, but recovered later as treatment proceeded. Patients treated with both IFN-α and IL-2 increased their Treg cell levels during the first 2 weeks after initiation of treatment. Patients who derived complete response (CR), partial response (PR), or stable disease (SD) from IFN-α monotherapy had lower Treg cell levels before treatment than did patients whose disease progressed. Low Treg cell levels before treatment may therefore be advantageous to subsequent immunotherapy with IFN-α, and predictive for treatment results in RCC patients.

Original languageEnglish
Pages (from-to)43-47
Number of pages5
JournalJournal of Interferon and Cytokine Research
Volume30
Issue number1
DOIs
Publication statusPublished - Jan 1 2010

All Science Journal Classification (ASJC) codes

  • Immunology
  • Cell Biology
  • Virology

Fingerprint Dive into the research topics of 'Influence of immunotherapy with interferon-α on regulatory T cells in renal cell carcinoma patients'. Together they form a unique fingerprint.

  • Cite this